“…Risk of bias for patient selection and applicability was low in 31/34 (91 %) studies [3, 18–45, 47, 50], high in one (6 %) [46] and unclear in two [48, 49] with high risk of bias due to patient selection criteria not being defined and retrospective study designs. The risk of bias due to conduct and interpretation of the index tests was low risk in 15/34 (44 %) [3, 18, 20, 21, 25, 28, 30, 32, 35–37, 40, 42, 43, 47], high risk in 4/34 (12 %) [38, 44–46] and unclear in 15/34 (44 %) [19, 22–24, 26, 27, 29, 31, 33, 34, 39, 41, 48–50]. Assessment of potential bias introduced by the reference standard was considered low risk in 19/34 (56 %) studies [3, 18, 19, 21, 22, 24, 28–31, 35, 36, 38, 40, 44, 47–50], high risk in nine (26 %) [20, 27, 32–34, 41, 43, 45, 46] and unclear in 6/34 (18 %) [23, 25, 26, 37, 39, 42], as there were a proportion of cases within the study that did not have a confirmed outcome or it was determined by clinical examination.…”